HLA match and cell doses for the 128 dominant CB units
| Characteristics . | Value . |
|---|---|
| Donor-recipient HLA-A, -B, -C, -DRB1, -DQB1 allele match | |
| 8-9/10 | 29 (23%) |
| 6-7/10 | 54 (42%) |
| 2-5/10 | 45 (35%) |
| Cell dose, median (range) | |
| Prefreeze TNC × 107/kg | 2.78 (1.56-16.49) |
| Prefreeze CD34+ cells × 105/kg | 0.94 (0.07-8.95) |
| Infused TNC × 107/kg | 2.18 (0.91-12.79) |
| Infused total CD34+ cells × 105/kg | 1.00 (0.1-5.68) |
| Infused viable CD34+ cells × 105/kg | 0.92 (0.08-4.77) |
| Infused CFU × 104/kg | 2.60 (0.17-18.43) |
| Infused viable CD3+ cells × 106/kg | 4.27 (0.8-15.3) |
| Characteristics . | Value . |
|---|---|
| Donor-recipient HLA-A, -B, -C, -DRB1, -DQB1 allele match | |
| 8-9/10 | 29 (23%) |
| 6-7/10 | 54 (42%) |
| 2-5/10 | 45 (35%) |
| Cell dose, median (range) | |
| Prefreeze TNC × 107/kg | 2.78 (1.56-16.49) |
| Prefreeze CD34+ cells × 105/kg | 0.94 (0.07-8.95) |
| Infused TNC × 107/kg | 2.18 (0.91-12.79) |
| Infused total CD34+ cells × 105/kg | 1.00 (0.1-5.68) |
| Infused viable CD34+ cells × 105/kg | 0.92 (0.08-4.77) |
| Infused CFU × 104/kg | 2.60 (0.17-18.43) |
| Infused viable CD3+ cells × 106/kg | 4.27 (0.8-15.3) |